WCG
CELL

Weaver Consulting Group’s PhenomeX Inc. Common Stock CELL Stock Holding History

Weaver Consulting Group’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-70
Closed -$5K – 972
2020
Q3 		$5K Buy
+70
New +$4.45K ﹤0.01% 707

Other funds holding CELL

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return

Weaver Consulting Group's CELL Position: Q4 2020 in Review

Weaver Consulting Group sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2020, closing a stake of 70 shares — an estimated $5K sold.

Weaver Consulting Group first reported a position in CELL in Q3 2020 and held it in 1 quarter. The position peaked at $5K in Q3 2020. 113 funds tracked by Wall St. Rank hold CELL as of Q4 2020.

  • Weaver Consulting Group reported no remaining PhenomeX Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Weaver Consulting Group sold 70 PhenomeX Inc. Common Stock shares in Q4 2020, an estimated $5K.
  • Weaver Consulting Group first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 1 quarter.
  • Weaver Consulting Group's PhenomeX Inc. Common Stock position peaked at $5K in Q3 2020.
  • 113 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.